Efficacy and Safety of CRT, Durvalumab and Surgery for SST

NCT04465968 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Superior Sulcus Tumor
Non-small Cell Lung Cancer Stage IIB
Non Small Cell Lung Cancer Stage III

Interventions

DRUG: Cisplatin
DRUG: S1
RADIATION: concurrent radiotherapy
DRUG: Durvalumab
PROCEDURE: Surgery
DRUG: Durvalumab

Sponsor

National Cancer Center Hospital East

Collaborators

[object Object]
[object Object]
[object Object]